TY - JOUR AU - Kane, D. AU - Stafford, L. AU - Bresnihan, B. AU - FitzGerald, O. PY - 2003 DA - 2003// TI - A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience JO - Rheumatology (Oxford) VL - 42 UR - https://doi.org/10.1093/rheumatology/keg384 DO - 10.1093/rheumatology/keg384 ID - Kane2003 ER - TY - JOUR AU - Ritchlin, C. T. AU - Haas-Smith, S. A. AU - Li, P. AU - Hicks, D. G. AU - Schwarz, E. M. PY - 2003 DA - 2003// TI - Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis JO - J Clin Invest VL - 111 UR - https://doi.org/10.1172/JCI200316069 DO - 10.1172/JCI200316069 ID - Ritchlin2003 ER - TY - JOUR AU - Singh, J. A. AU - Guyatt, G. AU - Ogdie, A. AU - Gladman, D. D. AU - Deal, C. AU - Deodhar, A. PY - 2019 DA - 2019// TI - Special article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis JO - Arthritis Rheum VL - 71 UR - https://doi.org/10.1002/art.40726 DO - 10.1002/art.40726 ID - Singh2019 ER - TY - JOUR AU - Coates, L. C. AU - Kavanaugh, A. AU - Mease, P. J. AU - Soriano, E. R. AU - Acosta-Felquer, M. L. AU - Armstrong, A. W. PY - 2016 DA - 2016// TI - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis JO - Arthritis Rheum VL - 68 ID - Coates2016 ER - TY - JOUR AU - Coates, L. C. AU - FitzGerald, O. AU - Merola, J. F. AU - Smolen, J. AU - Mens, L. J. J. AU - Bertheussen, H. PY - 2018 DA - 2018// TI - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology consensus-based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis JO - Arthritis Rheum VL - 70 UR - https://doi.org/10.1002/art.40391 DO - 10.1002/art.40391 ID - Coates2018 ER - TY - STD TI - SIMPONI ARIA (golimumab) injection, for intravenous use prescribing information. http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/SIMPONI-pi.pdf. Accessed 08 Aug 2018. UR - http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/SIMPONI-pi.pdf ID - ref6 ER - TY - JOUR AU - Kavanaugh, A. AU - Heijde, D. AU - McInnes, I. B. AU - Mease, P. AU - Krueger, G. G. AU - Gladman, D. D. PY - 2012 DA - 2012// TI - Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.34436 DO - 10.1002/art.34436 ID - Kavanaugh2012 ER - TY - JOUR AU - Kavanaugh, A. AU - Heijde, D. AU - Beutler, A. AU - Gladman, D. AU - Mease, P. AU - Krueger, G. G. PY - 2016 DA - 2016// TI - Radiographic progression of patients with psoriatic arthritis who achieve minimal disease activity in response to golimumab therapy: results through 5 years of a randomized, placebo-controlled study JO - Arthritis Care Res VL - 68 UR - https://doi.org/10.1002/acr.22576 DO - 10.1002/acr.22576 ID - Kavanaugh2016 ER - TY - JOUR AU - Kavanaugh, A. AU - Husni, M. E. AU - Harrison, D. D. AU - Kim, L. AU - Lo, K. H. AU - Leu, J. H. PY - 2017 DA - 2017// TI - Safety and efficacy of intravenous golimumab in patients with active psoriatic arthritis: results through week twenty-four of the GO-VIBRANT study JO - Arthritis Rheum VL - 69 UR - https://doi.org/10.1002/art.40226 DO - 10.1002/art.40226 ID - Kavanaugh2017 ER - TY - STD TI - Husni ME, Kavanaugh A, Murphy F, Rekalov D, Harrison DD, Kim L, et al. Efficacy and safety of intravenous golimumab through 1 year in patients with active psoriatic arthritis. Arthritis Care Res. 2019. https://doi.org/10.1002/acr.23905. ID - ref10 ER - TY - JOUR AU - Taylor, W. AU - Gladman, D. AU - Helliwell, P. AU - Marchesoni, A. AU - Mease, P. AU - Mielants, H. PY - 2006 DA - 2006// TI - Classification criteria for psoriatic arthritis: development of new criteria from a large international study JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21972 DO - 10.1002/art.21972 ID - Taylor2006 ER - TY - JOUR AU - Felson, D. T. AU - Anderson, J. J. AU - Boers, M. AU - Bombardier, C. AU - Furst, D. AU - Goldsmith, C. PY - 1995 DA - 1995// TI - American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380602 DO - 10.1002/art.1780380602 ID - Felson1995 ER - TY - JOUR AU - Fries, J. F. AU - Spitz, P. AU - Kraines, R. G. AU - Holman, H. R. PY - 1980 DA - 1980// TI - Measurement of patient outcome in arthritis JO - Arthritis Rheum VL - 23 UR - https://doi.org/10.1002/art.1780230202 DO - 10.1002/art.1780230202 ID - Fries1980 ER - TY - JOUR AU - Healy, P. J. AU - Helliwell, P. S. PY - 2008 DA - 2008// TI - Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis JO - Arthritis Rheum VL - 59 UR - https://doi.org/10.1002/art.23568 DO - 10.1002/art.23568 ID - Healy2008 ER - TY - JOUR AU - Gladman, D. D. AU - Inman, R. D. AU - Cook, R. J. AU - Maksymowych, W. P. AU - Braun, J. AU - Davis, J. C. PY - 2007 DA - 2007// TI - International spondyloarthritis interobserver reliability exercise—the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis JO - J Rheumatol VL - 34 ID - Gladman2007 ER - TY - JOUR AU - Gladman, D. D. AU - Ziouzina, O. AU - Thavaneswaran, A. AU - Chandran, V. PY - 2013 DA - 2013// TI - Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era JO - J Rheumatol VL - 40 UR - https://doi.org/10.3899/jrheum.130163 DO - 10.3899/jrheum.130163 ID - Gladman2013 ER - TY - JOUR AU - Fredriksson, T. AU - Pettersson, U. PY - 1978 DA - 1978// TI - Severe psoriasis--oral therapy with a new retinoid JO - Dermatologica. VL - 157 UR - https://doi.org/10.1159/000250839 DO - 10.1159/000250839 ID - Fredriksson1978 ER - TY - JOUR AU - Coates, L. C. AU - Fransen, J. AU - Helliwell, P. S. PY - 2010 DA - 2010// TI - Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2008.102053 DO - 10.1136/ard.2008.102053 ID - Coates2010 ER - TY - JOUR AU - Coates, L. C. AU - Helliwell, P. S. PY - 2016 DA - 2016// TI - Defining low disease activity states in psoriatic arthritis using novel composite disease instruments JO - J Rheumatol VL - 43 UR - https://doi.org/10.3899/jrheum.150826 DO - 10.3899/jrheum.150826 ID - Coates2016 ER - TY - JOUR AU - Helliwell, P. S. AU - FitzGerald, O. AU - Fransen, J. AU - Gladman, D. D. AU - Kreuger, G. G. AU - Callis-Duffin, K. PY - 2013 DA - 2013// TI - The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201341 DO - 10.1136/annrheumdis-2012-201341 ID - Helliwell2013 ER - TY - JOUR AU - Helliwell, P. S. AU - Kavanaugh, A. PY - 2014 DA - 2014// TI - Comparison of composite measures of disease activity in psoriatic arthritis using data from an interventional study with golimumab JO - Arthritis Care Res VL - 66 UR - https://doi.org/10.1002/acr.22204 DO - 10.1002/acr.22204 ID - Helliwell2014 ER - TY - JOUR AU - Kavanaugh, A. AU - Puig, L. AU - Gottlieb, A. B. AU - Ritchlin, C. AU - You, Y. AU - Li, S. PY - 2016 DA - 2016// TI - Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2) JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-209068 DO - 10.1136/annrheumdis-2015-209068 ID - Kavanaugh2016 ER - TY - STD TI - 36-Item Short Form Survey (SF-36). https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html. Accessed 07 Aug 2019. UR - https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html ID - ref23 ER - TY - JOUR AU - Helliwell, P. S. AU - FitzGerald, O. AU - Fransen, J. PY - 2014 DA - 2014// TI - Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response JO - J Rheumatol VL - 41 UR - https://doi.org/10.3899/jrheum.140172 DO - 10.3899/jrheum.140172 ID - Helliwell2014 ER - TY - JOUR AU - Schoels, M. M. AU - Aletaha, D. AU - Alasti, F. AU - Smolen, J. S. PY - 2016 DA - 2016// TI - Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207507 DO - 10.1136/annrheumdis-2015-207507 ID - Schoels2016 ER - TY - JOUR AU - Aletaha, D. AU - Smolen, J. S. PY - 2007 DA - 2007// TI - The simplified disease activity index (SDAI) and clinical disease activity index (CDAI) to monitor patients in standard clinical care JO - Best Pract Res Clin Rheumatol VL - 21 UR - https://doi.org/10.1016/j.berh.2007.02.004 DO - 10.1016/j.berh.2007.02.004 ID - Aletaha2007 ER - TY - JOUR AU - Kavanaugh, A. AU - Husni, M. E. AU - Harrison, D. D. AU - Kim, L. AU - Lo, K. H. AU - Noonan, L. PY - 2019 DA - 2019// TI - Radiographic progression inhibition with intravenous golimumab in psoriatic arthritis: week 24 results of a phase III, randomized, double-blind, placebo-controlled trial JO - J Rheumatol VL - 46 UR - https://doi.org/10.3899/jrheum.180681 DO - 10.3899/jrheum.180681 ID - Kavanaugh2019 ER - TY - JOUR AU - Heijde, D. M. F. M. AU - Leeuwen, M. A. AU - Riel, P. L. C. M. AU - Koster, A. M. AU - van ‘t Hof, M. A. AU - Rijswijk, M. H. PY - 1992 DA - 1992// TI - Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis JO - Arthritis Rheum VL - 35 UR - https://doi.org/10.1002/art.1780350105 DO - 10.1002/art.1780350105 ID - Heijde1992 ER - TY - JOUR AU - Heijde, D. AU - Sharp, J. AU - Wassenberg, S. AU - Gladman, D. D. PY - 2005 DA - 2005// TI - Psoriatic arthritis imaging: a review of scoring methods JO - Ann Rheum Dis VL - 64 ID - Heijde2005 ER - TY - JOUR AU - Sankoh, A. J. AU - Li, H. AU - D'Agostino, R. B. PY - 2014 DA - 2014// TI - Use of composite endpoints in clinical trials JO - Stat Med VL - 33 UR - https://doi.org/10.1002/sim.6205 DO - 10.1002/sim.6205 ID - Sankoh2014 ER - TY - JOUR AU - Landewé, R. AU - Ritchlin, C. T. AU - Aletaha, D. AU - Zhang, Y. AU - Ganz, F. AU - Hojnik, M. PY - 2019 DA - 2019// TI - Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity JO - Rheumatology (Oxford) VL - 58 UR - https://doi.org/10.1093/rheumatology/key417 DO - 10.1093/rheumatology/key417 ID - Landewé2019 ER - TY - JOUR AU - Smolen, J. S. AU - Han, C. AU - Bala, M. AU - Maini, R. N. AU - Kalden, J. R. AU - Heijde, D. PY - 2005 DA - 2005// TI - Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.20982 DO - 10.1002/art.20982 ID - Smolen2005 ER - TY - JOUR AU - Smolen, J. S. AU - Han, C. AU - Heijde, D. M. F. M. AU - Emery, P. AU - Bathon, J. M. AU - Keystone, E. PY - 2009 DA - 2009// TI - Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.090019 DO - 10.1136/ard.2008.090019 ID - Smolen2009 ER - TY - JOUR AU - Landewé, R. AU - Heijde, D. AU - Klareskog, L. AU - Vollenhoven, R. AU - Fatenejad, S. PY - 2006 DA - 2006// TI - Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22143 DO - 10.1002/art.22143 ID - Landewé2006 ER - TY - JOUR AU - Melagraki, G. AU - Leonis, G. AU - Ntougkos, E. AU - Rinotas, V. AU - Papaneophytou, C. AU - Mavromoustakos, T. PY - 2018 DA - 2018// TI - Current status and future prospects of small-molecule protein-protein interaction (PPI) inhibitors of tumor necrosis factor (TNF) and receptor activator of NF-κB ligand (RANKL) JO - Curr Top Med Chem VL - 18 UR - https://doi.org/10.2174/1568026618666180607084430 DO - 10.2174/1568026618666180607084430 ID - Melagraki2018 ER - TY - JOUR AU - Schett, G. PY - 2009 DA - 2009// TI - Osteoimmunology in rheumatic diseases JO - Arthritis Res Ther. VL - 11 UR - https://doi.org/10.1186/ar2571 DO - 10.1186/ar2571 ID - Schett2009 ER - TY - JOUR AU - Sucur, A. AU - Jajic, Z. AU - Artukovic, M. AU - Matijasevic, M. I. AU - Anic, B. AU - Flegar, D. PY - 2017 DA - 2017// TI - Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells JO - Arthritis Res Ther VL - 19 UR - https://doi.org/10.1186/s13075-017-1337-6 DO - 10.1186/s13075-017-1337-6 ID - Sucur2017 ER - TY - JOUR AU - Souza, P. P. C. AU - Lerner, U. H. PY - 2013 DA - 2013// TI - The role of cytokines in inflammatory bone loss JO - Immunol Investig VL - 42 UR - https://doi.org/10.3109/08820139.2013.822766 DO - 10.3109/08820139.2013.822766 ID - Souza2013 ER - TY - JOUR AU - Wagner, C. L. AU - Visvanathan, S. AU - Elashoff, M. AU - McInnes, I. B. AU - Mease, P. J. AU - Krueger, G. G. PY - 2013 DA - 2013// TI - Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201697 DO - 10.1136/annrheumdis-2012-201697 ID - Wagner2013 ER -